
The inhalation of
one marijuana cigarette per day over a 20-year period is not associated with
adverse changes in lung health, according todata published online ahead of print in the journal Annals of
the American Thoracic Society.
Investigators at Emory University in
Atlanta assessed marijuana smoke exposure and lung health in a large
representative sample of US adults age 18 to 59. Researchers reported that
cannabis exposure was not associated with FEV1 (forced expiratory volume)
decline or deleterious change in spirometric values of small airways
disease.
Authors further reported that marijuana smoke exposure may even
be associated with some protective lung effects among long-term smokers of
tobacco. Investigators acknowledged, “[T]he pattern of marijuana’s effects seems
to be distinctly different when compared to that of tobacco
use.”
Researchers also acknowledged that habitual cannabis consumers were
more likely to self-report increased symptoms of bronchitis, a finding that is
consistent with previous literature. Separate
studies indicate that
subjects who vaporize cannabis report fewer adverse respiratory symptoms than do
those who inhale combustive marijuana smoke.
Authors concluded, “[I]n a
large representative sample of US adults, ongoing use of marijuana is associated
with increased respiratory symptoms of bronchitis without a significant
functional abnormality in spirometry, and cumulative marijuana use under 20
joint-years is not associated significant effects on lung function.”
This
study is the largest cross-sectional analysis to date examining the relationship
between marijuana use and spirometric parameters of lung health.
A separate
study published in 2012 in The Journal of the American Medical
Association (JAMA) similarly reported that cumulative marijuana smoke exposure
over a period of up to 7 joint-years (the equivalent of up to one marijuana
cigarette per day for seven years) was not associated with adverse effects on
pulmonary function.
A 2013
review also published in the Annals of the American Thoracic Society
acknowledged that marijuana a smoke exposure was not positively associated with
the development of lung cancer, chronic obstructive pulmonary disease (COPD),
emphysema, or bullous lung disease. It concluded: “[H]abitual use of marijuana
alone does not appear to lead to significant abnormalities in lung function.
Findings from a limited number of well-designed epidemiological studies do not
suggest an increased risk of either lung or upper airway cancer from light or
moderate use. … Overall, the risks of pulmonary complications of regular use of
marijuana appear to be relatively small and far lower than those of tobacco
smoking.”
You may view an abstract of this latest study, “Effects of marijuana exposure on expiratory airflow: A study of adults who participated in the US National Health and Nutrition Examination Study,” here.